Article, 2024

Mortality in patients with incident rheumatoid arthritis and depression: a Danish cohort study of 11 071 patients and 55 355 comparators

Rheumatology, ISSN 1462-0324, 1462-0332, Volume 63, 3, Pages 680-688, 10.1093/rheumatology/kead259

Contributors

Pedersen J.K. 0000-0003-2531-9547 (Corresponding author) [1] [2] Wang L. [3] Risbo N. [3] Pedersen A.B. 0000-0002-3288-9401 [3] [4] Andersen K. 0000-0003-0456-5634 [1] [5] Ellingsen T. 0000-0003-0426-4962 [1] [2]

Affiliations

  1. [1] University of Southern Denmark
  2. [NORA names: SDU University of Southern Denmark; University; Denmark; Europe, EU; Nordic; OECD];
  3. [2] Odense University Hospital
  4. [NORA names: Region of Southern Denmark; Hospital; Denmark; Europe, EU; Nordic; OECD];
  5. [3] Aarhus University Hospital
  6. [NORA names: Central Denmark Region; Hospital; Denmark; Europe, EU; Nordic; OECD];
  7. [4] Aarhus University
  8. [NORA names: AU Aarhus University; University; Denmark; Europe, EU; Nordic; OECD];
  9. [5] Mental Health Services in the Region of Southern Denmark
  10. [NORA names: Region of Southern Denmark; Hospital; Denmark; Europe, EU; Nordic; OECD]

Abstract

Objectives: In patients with RA, the association between mortality and depression has been investigated only in patients with prevalent RA. In this study, we estimated the mortality risk associated with depression, defined as the first filling of a prescription for antidepressants, in patients with incident RA and background population comparators. Methods: From 2008 to 2018, we identified patients with incident RA in the nationwide Danish rheumatologic database, DANBIO. For each patient, we randomly selected five comparators. Participants were not treated with antidepressants or diagnosed with depression 3 years prior to the index date. From other registers we collected data on socioeconomic status, mortality and cause of death using unique personal identifiers. Using Cox models, we calculated hazard rate ratios (HRR) with 95% CI. Results: In depressed patients with RA vs patients without depression, adjusted HRR for all-cause mortality was 5.34 (95% CI 3.02, 9.45) during 0–2 years and 3.15 (95% CI 2.62, 3.79) during the total follow-up period, and highest in patients <55 years with HRR 8.13 (95% CI 3.89, 17.02). In comparators with depression vs comparators without depression, the association with mortality was similar to that in patients with RA. There were no unnatural causes of death among depressed patients with RA. The most frequent natural causes of death were cancer, cardiovascular disease, stroke and pneumonia. Conclusion: In patients with RA, depression was a predictor of death but with a strength similar to that in matched comparators.

Keywords

RA, antidepressive agents, cohort studies, depression, mortality

Funders

  • Gigtforeningen

Data Provider: Elsevier